NEWS: Chlorpheniramine Naloxone Oxazepam Prednisolone Plendil Insulin. Neomycin Amoxil Furazolidone Thiotepa Dilantin Plendil! Amitriptyline Trandolapril Risperdal Benadryl Naproxen Dulcolax Beclomethasone Morphine Quinidine Aldara Dolasetron Ethanol Acetylcholine Phenacetin! Fenoterol Avalide Diethylpropion Cytomel, Elocon Tolazamide Disopyramide Glimepiride Cycloserine Chlordiazepoxide: Naloxone Cephalothin. Benicar Dextroamphetamine Hexoprenaline Levitra Podofilox Midodrine: Cyproheptadine Isradipine Fenoprofen Cefamandole, Darvocet Granisetron Cefatrizine Estrone Pyridostigmine Butalbital Belladonna Phenylephrine Levlen Trovafloxacin Avodart Warfarin Ethinyl Gemfibrozil. Mephentermine Cefprozil Nylidrin Diphenoxylate Xanax Methantheline Adipex Ibuprofen? Carbachol Dyphylline Chlordiazepoxide Dantrolene? Vytorin Ceftriaxone Phencyclidine Indinavir? Paregoric Demerol Levothyroxine Ceftibuten Iodoquinol Cycrimine Buclizine Mefloquine, Danazol Colace Zoloft Primidone: Viagra Piroxicam Cardizem Cloxacillin Promazine Paromomycin Pilocarpine Butorphanol Pravastatin Toprol Epoprostenol Promazine Digitalis Nizoral Foradil Oxycontin Hydroflumethiazide Enoxaparin Dilaudid Piperidolate Singulair Tretinoin Thiothixene Propylthiouracil Bethanechol Erythrityl Fentanyl Prochlorperazine! Lopressor Dimethindene. Isopropamide Cholestyramine! Demeclocycline Piperacillin Amikacin Prometrium Zileuton Lozol Nitrofurantoin Moxalactam Trimethoprim Sinemet Corticotropin Carbenicillin: Esomeprazole Miconazole Doxepin Hydromorphone Hydromorphone Desyrel! Probucol Echothiophate Ethchlorvynol Hydroxychloroquine! Hydrochlorothiazide Prozac Trimetrexate Somatostatin Adapalene Doxorubicin? Disulfiram Streptomycin Pheniramine Lunesta Ergocalciferol Pargyline Bleomycin Maprotiline Pantothenic Terbinafine Penicillin Acarbose Cerivastatin Amaryl Guanabenz Climara: Mestranol Aminopterin Clotrimazole Chantix Trientine Amantadine Cocaine Heroin Aprotinin Carteolol Mifepristone Oxytetracycline. Naratriptan Xanax: Cosopt Metoprolol, Clomocycline Flagyl Phensuximide Cortisol Botox Acebutolol Ditropan Chlortetracycline Diovan Nialamide! Betamethasone Chlorothiazide Suboxone Ketoprofen Protonix Lotrel! Methamphetamine Dichlorphenamide Perindopril Isocarboxazid: Iodine Prednisone Augmentin Sildenafil! Tacrolimus Tolmetin! Ethinamate Dalteparin Pseudoephedrine Thiabendazole Acarbose Vytorin Norvasc Diethylstilbestrol Nafcillin Acyclovir. Protriptyline Yohimbine Daunorubicin Guaifenesin Sulfasalazine Celiprolol Amoxapine Bricanyl Gatifloxacin Oxybutynin Diethylstilbestrol Demecarium Medrol Concerta Methacycline Vincristine Butorphanol Mucomyst Digoxin Dioxyline Trileptal Methoxsalen Acebutolol Casanthranol: Pediacare Ergocalciferol:

Archive for the 'Personal Finance' Category


Guidelines for Withdrawal Rates and Portfolio Safety During Retirement

For individuals drawing on retirement funds, a 4% withdrawal rate is generally recommended to result in only a small chance of the portfolio running out of money. In the October 2007 Journal of Financial Planning Spitzer, Strieter and Singh simulate thousands of 30-year periods to assess the overall probability of running out of funds.

They find that a standard 50/50 split between stocks and bonds can allow for a 4.4% withdrawal rate with just a 10% chance of depleting funds. Withdrawal rates of up to 6% can be supported with stock allocations of 75% or more.

Posted on 10th July 2008
Under: Asset Allocation, FInancial Planning, Investing in Stocks, Investing in bonds, Investment Returns, Personal Finance, Portfolio Management, Research, Risk Management | No Comments »

Longevity Annuities

Longevity annuities exchange an up-front payment for a stream of payments that will begin some years after retirement. For example, the annuity may be purchased when the investor is 65, but only begin to pay benefits when the investor turns 80. Benefits will continue for the remainder of the investor’s life.

Investment annuity payouts per dollar invested are much higher than immediate annuity payments for several reasons:

  • The lack of payouts in early years allows for greater compounding benefits on investment returns
  • The shorter remaining expected life span after payouts begin allows for each payment to be larger
  • Potential annuitants who die before reaching the target age subsidize returns for those who live longer

In the January/February 2008 Financial Analysts Journal, Scott argues that many investors will benefit from an allocation to longevity annuities, and that the optimal bundle depends upon the percentage of total assets the annuitant is willing to allocate to annuities. The greater the proportion annuitized, the earlier payments should start.

Posted on 4th May 2008
Under: Alternative Assets, Asset Allocation, Investment Returns, Personal Finance, Risk Management | No Comments »

Defined Benefit versus Defined Contribution Plans

Retirement plans generally come in one of two varieties: defined benefit (DB) or defined contribution (DC). In a defined benefit plan, the plan sponsor promises a specific future benefit, with no specific present obligation. In a defined contribution plan, the sponsor’s present contribution is specified but the future benefit is not. The distinction raises some important differences between the plans from both the empoyee’s and the employer’s perspective:

  1. For the plan sponsor, DC plan obligations are fully met when the initial contribution is made. Sponsors bear a future liability in a DB plan.
  2. Investment risk is borne by the sponsor of a DB plan, but by the participants in a DC plan.
  3. Participants in a DB plan bear the risk of an early plan termination. There is no such risk to participants in a DC plan, because the participants own their own accounts.
  4. DC plans offer portability to participants changing jobs.

Posted on 13th November 2007
Under: Active Management, FInancial Planning, Personal Finance, Portfolio Management | 1 Comment »

As Goes January…

In the November 2006 Journal of Financial Economics Cooper, McConnell and Ovtchinnikov examine whether investment returns in January have predictive power over returns for the subsequent 11 months. Between 1940 and 2003, when the market-weighted portfolio is positive in January returns for the remainder of the year have averaged 14.8% and when January returns were negative the remaining 11 months returned an average of just 2.92%.

The authors find no explanatory value from business cycle variables, presidential party affiliation, or consumer sentiment. Further, the results occur independently of other recognized factors such as portfolio weighting, market capitalization or valuation.

Posted on 21st July 2007
Under: FInancial Planning, Investing in Stocks, Investment Returns, Personal Finance, Portfolio Management, Research | No Comments »

Investor Overconfidence and Trading Volume

Behavioral Finance suggests that overconfidence will cause investors to attribute market-related returns to their own skill level and trade more frequently when markets are rising than when they are falling. In the Winter 2006 Review of Financial Studies Statman, Thorley and Vorkink examine the relationship between past returns and stock turnover in portfolios. This is related to the disposition effect, in which investors will realize gains but delay realizing losses.

The authors find a statistically and economically significant positive relationship between market turnover and lagged market returns, consistent with the overconfidence hypothesis. They also find that individual security turnover is related to both market and security specific returns, supportive of both overconfidence and the disposition effect. Finally, they find that the effect was smaller after 1982 and in large cap stocks, which may be explained by larger institutional (rather than individual) participation in those subsets.

Posted on 20th July 2007
Under: Behavioral Finance, Investing in Stocks, Investment Returns, Personal Finance, Research | No Comments »

Lifetime Financial Advice

Much of financial planning fails to account for the investor’s human capital, and how that interacts with financial capital. Ibbotson et. al. address the issue in depth in a recent CFA Institute Monograph, Lifetime Financial Advice: Human Capital, Asset Allocation, and Insurance.

Human capital, in the context of the monograph, is simply the present value of a person’s future earnings. When the investor is young, human capital likely far exceeds financial capital. As retirement approaches, financial capital needs to be able to replace the income as human capital dwindles.

The monograph contains a variety of models and case studies, but some of the important considerations include:

  • Security selection should include assets with low correlation to the investor’s income. Too many people, for example, invest too much of their human and financial capital in their employer.
  • Insurance products to protect against premature death (life insurance) and unexpected longevity (annuities) must be a part of the overall plan.
  • The types of plan in which the investor participates must be considered to develop the optimal mix of lifetime income and bequeath.

Posted on 16th July 2007
Under: Book Reviews, FInancial Planning, Personal Finance, Portfolio Management | No Comments »

ss_blog_claim=03ab3ad958d87eac8403bc8f2fe29a6d